With respect to breast cancer, lower serum Acrp30 levels have been reported for postmenopausal women with breast cancer (Bondanelli et al, 2001; Miyoshi et al, 2003; Mantzoros et al, 2004). Here, ADIPOQ is linked to breast carcinoma.